Trial intelligence / Profile preview

Comparative efficacy of Jaungo versus non-steroidal moisturizer for radiation-induced dermatitis in breast cancer

KCT0005971Phase 2Not yet recruiting

Sponsor
Ministry of Health & Welfare
Start
Mar 2021
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of Jaungo in breast cancer and radiodermatitis (2 arms), sponsored by Ministry of Health & Welfare. Planned start Mar 2021; status: not yet recruiting.

02

Drugs

Jaungo
03

Conditions

breast cancerradiodermatitis

Beyond the preview

Go deeper on KCT0005971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0005971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call